Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

被引：0
作者：
Nassim Kamar
Elisabeth Cassuto
Giovanni Piotti
Mirco Govoni
Giorgia Ciurlia
Silvia Geraci
Gianluigi Poli
Gabriele Nicolini
Christophe Mariat
Marie Essig
Paolo Malvezzi
Yannick Le Meur
Valerie Garrigue
Arnaud Del Bello
Lionel Rostaing
机构：
[1] CHU Rangueil,Departments of Nephrology and Organ Transplantation
[2] INSERM U1043,Unité de Transplantation Rénale
[3] IFR-BMT,Kidney and Pancreas Transplantation Unit
[4] Université Paul Sabatier,Global Clinical Development, Department of Clinical Pharmacology
[5] Hôpital Pasteur 2,Nephrology Unit
[6] CHU Nice,Service de Néphrologie, Dialyse, Aphérèses et Transplantation
[7] University Hospital of Parma,Service de Nephrologie
[8] Chiesi Farmaceutici,Transplantation Rénale et Hémodialyse, CHRU Brest
[9] CHU Saint-Etienne,undefined
[10] CHU Limoges,undefined
[11] CHU Grenoble Alpes,undefined
[12] Hôpital de la Cavale Blanche,undefined
[13] Service de Néphrologie-Transplantation-Dialyse péritonéale CHU Lapeyronie,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Advagraf; De novo kidney transplantation; Envarsus; LCPT; Pharmacokinetics; PR Tac; Tacrolimus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 477
页数：15
相关论文
共 126 条
[1]  
Hart A(2018)OPTN/SRTR 2016 annual data report: kidney Am J Transplant 18 18-113
[2]  
Smith JM(2013)Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation Eur J Hosp Pharm Sci Pract. 20 302-307
[3]  
Skeans MA(2011)Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Drugs. 71 1561-1577
[4]  
Gustafson SK(2010)Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study Am J Transplant 10 2632-2643
[5]  
Wilk AR(2017)A steady-state head-to-head pharmacokinetic comparison of all FK-506 (Tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm. Three-period crossover study Am J Transpl. 17 432-442
[6]  
Robinson A(2014)Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial Am J Transplant 14 2796-2806
[7]  
Johnston A(2013)Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial Am J Transplant 13 760-769
[8]  
Barraclough KAIN(2016)Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial Am J Kidney Dis. 67 648-659
[9]  
Johnson DW(2014)Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations Expert Rev Clin Immunol. 10 1567-1579
[10]  
Campbell SB(2015)Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients Clin Pharmacokinet 54 993-1025
12345678910